Stocks · Healthcare · Medical - Care Facilities
Starling Oncology, Inc. STLN
$6.35 +2.09% Close, Oct 2, 2026 · NASDAQ · Market cap $634.9M
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 42%
- Gross marginBottom 13%
- Operating marginTop 47%
- Accruals (lower is better)Top 13%
- Interest coverBottom 44%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 43%
- Free-cash-flow yieldTop 37%
- EBITDA / enterprise valueTop 47%
- Sales / enterprise valueTop 13%
Strength and persistence of the price trend, including versus the S&P 500.
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 23%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 10%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 21%
- Maximum drawdown, 3 yearsTop 2%
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Gross margin | 15.7% | — | Bottom 13% | |
| Operating margin | -4.4% | — | Top 47% | |
| Net margin | -6.2% | — | — | |
| Free-cash-flow margin | -0.6% | — | — | |
| Return on invested capital | -28.8% | — | Bottom 42% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -20.5%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.9%
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -3.4×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -2.40%
- Shareholder yield
- -2.40%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jun 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 1 of 4
- Average EPS surprise, last 4
- -15.4%
- Average 2-day reaction, last 8
- -0.8%
- Positive 20 days after report
- 1 of 1
Analysts
- Analysts with a rating
- 3
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | -25.0% | -0.8% | +25.6% | +21.1% | — |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.08 | -$0.06 | -25.0% | $161.3M |
| May 7, 2026 | -$0.02 | -$0.09 | +77.1% | $147.4M |
| Aug 13, 2025 | -$0.15 | -$0.12 | -25.0% | $119.8M |
| May 14, 2025 | -$0.21 | — | — | $104.4M |
| Aug 13, 2024 | -$0.17 | -$0.09 | -88.9% | $98.6M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 1.19× | — | — | Top 13% |
| Free-cash-flow yield | -0.52% | — | — | Top 37% |
| Earnings yield | -4.72% | — | — | Top 43% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 14
- Distance from 50-day average
- +3.9%
- RSI (14)
- 48.4
- Relative volume
- 0.60×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 76.0%
- Current drawdown from 1-year high
- -9.9%
- Maximum drawdown, 3 years
- -24.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jul 14, 2026 | Jul 29, 2026 | -24.0% | 11 days | 7 days (Aug 7, 2026) |
| Sep 22, 2026 | Oct 1, 2026 | -11.8% | 7 days | Not yet recovered |
| Aug 19, 2026 | Aug 31, 2026 | -11.3% | 8 days | 13 days (Sep 18, 2026) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $634.9M
- EPS, diluted (TTM)
- -$0.30
- Revenue (TTM)
- $587.2M
| FY 2025 | |
|---|---|
| Revenue | $502.7M |
| Gross profit | $76.4M |
| Operating income | -$36.1M |
| Net income | -$60.6M |
| EPS (diluted) | -$0.54 |
| Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|
| Revenue | $136.6M | $142.0M | $147.4M | $161.3M |
| Net income | -$16.5M | -$7.5M | -$2.5M | -$9.8M |
| EPS (diluted) | -$0.14 | -$0.06 | -$0.02 | -$0.08 |
| FY 2025 | |
|---|---|
| Operating cash flow | -$24.6M |
| Capital expenditure | -$3.2M |
| Free cash flow | -$27.8M |
| Dividends paid | $0 |
| Net share buybacks | $32.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $41.1M
- Total assets
- $178.2M
- Total liabilities
- $203.1M
- Total debt
- $104.5M
- Net debt
- $63.4M
- Shareholders’ equity
- -$24.9M
As of Jun 30, 2026 (filed Jun 30, 2026).
Short interest
- Shares sold short
- 7,053,920
- Days to cover
- 7.35
- Change vs previous report
- +3.5%
FINRA short interest, settlement date Sep 15, 2026.